NCT01253369 2019-04-23
Pazopanib in Patients With Relapsed or Refractory Small Cell Lung Cancer
Dana-Farber Cancer Institute
Phase 2 Completed
Clinical Trials
3 trialsNCT01262820 2017-03-07
LCCC0921
UNC Lineberger Comprehensive Cancer Center
Phase 2 Completed
NCT01027598 2016-01-29
Randomized, Double-Blind Trial of Erlotinib/Pazopanib or Erlotinib/Placebo in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer
SCRI Development Innovations, LLC
Phase 2 Completed